首页> 外文期刊>Chromatographia >Determination of Enantiomeric Purity of GSK962040 Based on Liquid Chromatography Using Chiral Stationary Phase Combined with a Pre-column Derivatization Procedure
【24h】

Determination of Enantiomeric Purity of GSK962040 Based on Liquid Chromatography Using Chiral Stationary Phase Combined with a Pre-column Derivatization Procedure

机译:基于液相色谱法使用手性固定相结合的液相色谱法与柱前衍生过程中的液相色谱法测定GSK962040的映体纯度

获取原文
获取原文并翻译 | 示例
           

摘要

A sensitive and accurate LC method was developed and further validated for the determination of enantiomeric purity of GSK962040. Before separation, a pre-column derivatization procedure was performed. Baseline separation with a resolution higher than 1.9 was accomplished within 15 min using a Chiralpak AD-H (250 x 4.6 mm; particle size 5 mu m) column, with n-hexane: 2-propanol (85:15 v/v) as mobile phase at a flow rate of 1 mL min(-1). The eluted analytes were subsequently detected with a UV detector at 260 nm. The effects of mobile phase components and temperature on enantiomeric selectivity as well as resolution of enantiomers were thoroughly investigated. The calibration curves were plotted within the concentration range between 4 and 200 mu g mL(-1) (n = 8), and recoveries between 98.15 and 101.48% were obtained, with relative standard deviation (RSD) lower than 1.42%. The LOD and LOQ for the Boc-GSK962040 were 1.23 and 4.15 mu g mL(-1) and for its enantiomer were 1.38 and 4.76 mu g mL(-1), respectively. The developed method was also evaluated and validated by analyzing bulk samples with different enantiomeric ratios of GSK962040. It was demonstrated that the method was accurate, robust and sensitive, and also had practical utilities for real analysis.
机译:开发并进一步验证了敏感和准确的LC方法,用于测定GSK962040的对映体纯度。分离之前,进行柱前衍生过程。使用Chiralpak Ad-H(250×4.6mm;粒径5μm)柱15分钟内完成高于1.9的分辨率高于1.9的基线分离,用正己烷:2-丙醇(85:15V / v)为流动相以1mL min(-1)。随后在260nm下用UV检测器检测洗脱的分析物。彻底研究了流动相组分和温度对对映体选择性的影响以及对映体的分辨率进行了彻底研究。绘制校准曲线在4-200μg(-1)(n = 8)之间的浓度范围内,得到98.15和101.48%的回收率,相对标准偏差(RSD)低于1.42%。 BOC-GSK962040的LOD和LOQ分别为1.23和4.15μg(-1),其对映体分别为1.38和4.76μg(-1)。还通过分析具有GSK962040的不同对映体比的批量样品来评估和验证开发的方法。结果表明,该方法是准确的,稳健和敏感的,并且还具有实际分析的实用实用程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号